Condition: Head and Neck Cancer · Sponsor: Centre Paul Strauss
This project aims to organise the sampling of blood and tumor at key points of the standard of care of patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (HNSCC). This will allow to identify new potential predictive biomarkers of efficacy of immunotherapy and to investigate the evolution of the tumoral microenvironment after successive systemic treatments.
This description comes directly from the study's public registry record.
Valérie SARTORI · 03 68 33 95 23 · promotion-rc@icans.eu
Manon VOEGELIN · 03 68 33 95 23 · promotion-rc@icans.eu
Always discuss trial participation with your own doctor first.
| Institut de cancérologie Strasbourg Europe | Strasbourg, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05328024